Skip to main content

Table 3 Antibiotic resistance profile

From: Detection of new SHV-12, SHV-5 and SHV-2a variants of extended spectrum Beta-lactamase in Klebsiella pneumoniae in Egypt

 

Panel of antibiotic tested

 

Disk diffusion*

ESBL Confirmation†

E-test‡

 

Ampicillin (AM)

Imipenem (IPM)

Cefepime (FEP)

Cephalothin (CF)

Ceftriaxone (CRO)

Cefpodoxime (CPD)

CAZ

CAZ/CLA ZONE

CTX

CTX/CLA zone

Sulfamethoxazole (SXT)

Ceftazidime (TZ)

Cefepime (PM0

Cephalothin (CE)

N(%) Cases with resistance phenotype

65 (100)

1 (3)

24 (37)

65 (100)

61 (94)

65 (100)

65 (100)

0 (0)

63 (97)

1 (1.5)

32 (49)

64 (98)

9 (14)

65 (100)

  1. The table is divided into three major categories to show the number and percent [N (%) ] of cases with ESBL phenotype by Disc diffusion*, double disc synergy test (for ESBL confirmation)† and E test results ‡ to SXT and other third generation antibiotics.